Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis

J.M. Kwakkel - van Erp; I.M. Haeck; A.W.M. Paantjens; E.A. van de Graaf; W.G. van Ginkel; M.J. Knol; M.S. de Bruin-Weller; J.W.J. Lammers; E.F. Knol; C.A.F.M. Bruijnzeel - Koomen; H.G. Otten

doi:10.1016/j.jaad.2010.02.015

Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis

J.M. Kwakkel - van Erp, I.M. Haeck, A.W.M. Paantjens, E.A. van de Graaf, W.G. van Ginkel, M.J. Knol, M.S. de Bruin-Weller, J.W.J. Lammers, E.F. Knol, C.A.F.M. Bruijnzeel - Koomen, H.G. Otten

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	e70-e72
Number of pages	3
Journal	Journal of the American Academy of Dermatology
Volume	63
Issue number	3
DOIs	https://doi.org/10.1016/j.jaad.2010.02.015
Publication status	Published - 2010

Keywords

Antigens, CD30
Biomarkers
Chemokine CCL17
Cyclosporine
Dermatitis, Atopic
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Male
Mycophenolic Acid
Observer Variation
Pilot Projects
Prognosis
Sensitivity and Specificity
Severity of Illness Index
Single-Blind Method
Tablets, Enteric-Coated
Treatment Outcome

Access to Document

10.1016/j.jaad.2010.02.015

Cite this

Kwakkel - van Erp, J. M., Haeck, I. M., Paantjens, A. W. M., van de Graaf, E. A., van Ginkel, W. G., Knol, M. J., de Bruin-Weller, M. S., Lammers, J. W. J., Knol, E. F., Bruijnzeel - Koomen, C. A. F. M., & Otten, H. G. (2010). Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis. Journal of the American Academy of Dermatology, 63(3), e70-e72. https://doi.org/10.1016/j.jaad.2010.02.015

@article{12cb255e85964b65a27345223d81e300,

title = "Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis",

keywords = "Antigens, CD30, Biomarkers, Chemokine CCL17, Cyclosporine, Dermatitis, Atopic, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Male, Mycophenolic Acid, Observer Variation, Pilot Projects, Prognosis, Sensitivity and Specificity, Severity of Illness Index, Single-Blind Method, Tablets, Enteric-Coated, Treatment Outcome",

author = "{Kwakkel - van Erp}, J.M. and I.M. Haeck and A.W.M. Paantjens and {van de Graaf}, E.A. and {van Ginkel}, W.G. and M.J. Knol and {de Bruin-Weller}, M.S. and J.W.J. Lammers and E.F. Knol and {Bruijnzeel - Koomen}, C.A.F.M. and H.G. Otten",

year = "2010",

doi = "10.1016/j.jaad.2010.02.015",

language = "English",

volume = "63",

pages = "e70--e72",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "3",

}

Kwakkel - van Erp, JM, Haeck, IM, Paantjens, AWM, van de Graaf, EA, van Ginkel, WG, Knol, MJ, de Bruin-Weller, MS, Lammers, JWJ, Knol, EF, Bruijnzeel - Koomen, CAFM & Otten, HG 2010, 'Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis', Journal of the American Academy of Dermatology, vol. 63, no. 3, pp. e70-e72. https://doi.org/10.1016/j.jaad.2010.02.015

Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis. / Kwakkel - van Erp, J.M.; Haeck, I.M.; Paantjens, A.W.M. et al.
In: Journal of the American Academy of Dermatology, Vol. 63, No. 3, 2010, p. e70-e72.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis

AU - Kwakkel - van Erp, J.M.

AU - Haeck, I.M.

AU - Paantjens, A.W.M.

AU - van de Graaf, E.A.

AU - van Ginkel, W.G.

AU - Knol, M.J.

AU - de Bruin-Weller, M.S.

AU - Lammers, J.W.J.

AU - Knol, E.F.

AU - Bruijnzeel - Koomen, C.A.F.M.

AU - Otten, H.G.

PY - 2010

Y1 - 2010

KW - Antigens, CD30

KW - Biomarkers

KW - Chemokine CCL17

KW - Cyclosporine

KW - Dermatitis, Atopic

KW - Dose-Response Relationship, Drug

KW - Drug Administration Schedule

KW - Female

KW - Humans

KW - Male

KW - Mycophenolic Acid

KW - Observer Variation

KW - Pilot Projects

KW - Prognosis

KW - Sensitivity and Specificity

KW - Severity of Illness Index

KW - Single-Blind Method

KW - Tablets, Enteric-Coated

KW - Treatment Outcome

U2 - 10.1016/j.jaad.2010.02.015

DO - 10.1016/j.jaad.2010.02.015

M3 - Article

C2 - 20708466

SN - 0190-9622

VL - 63

SP - e70-e72

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 3

ER -

Kwakkel - van Erp JM, Haeck IM, Paantjens AWM, van de Graaf EA, van Ginkel WG, Knol MJ et al. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis. Journal of the American Academy of Dermatology. 2010;63(3):e70-e72. doi: 10.1016/j.jaad.2010.02.015